Envestnet Portfolio Solutions
WST icon

Envestnet Portfolio Solutions’s West Pharmaceutical WST Stock Holding History

Envestnet Portfolio Solutions’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$677K Buy
1,886
+209
+12% +$63.9K ﹤0.01% 866
2026
Q1 		$420K Sell
1,677
-2,792
-62% -$695K ﹤0.01% 975
2025
Q4 		$1.23M Sell
4,469
-225
-5% -$61.5K ﹤0.01% 694
2025
Q3 		$1.23M Sell
4,694
-2,138
-31% -$520K ﹤0.01% 673
2025
Q2 		$1.49M Sell
6,832
-2,911
-30% -$622K 0.01% 660
2025
Q1 		$2.18M Sell
9,743
-2,266
-19% -$625K 0.01% 556
2024
Q4 		$3.93M Sell
12,009
-11
-0.1% -$3.46K 0.01% 455
2024
Q3 		$3.61M Sell
12,020
-534
-4% -$164K 0.01% 483
2024
Q2 		$4.14M Buy
12,554
+49
+0.4% +$17.3K 0.01% 417
2024
Q1 		$4.95M Sell
12,505
-13
-0.1% -$4.81K 0.02% 379
2023
Q4 		$4.41M Buy
12,518
+10
+0.1% +$3.54K 0.02% 358
2023
Q3 		$4.69M Buy
+12,508
New +$4.84M 0.02% 323

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Envestnet Portfolio Solutions's WST Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its West Pharmaceutical (WST) stake by 12% in Q2 2026, buying an estimated $63.9K and bringing the position to 1,886 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Envestnet Portfolio Solutions first reported a position in WST in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.95M in Q1 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Envestnet Portfolio Solutions held 1,886 shares of West Pharmaceutical worth $677K as of Q2 2026.
  • Envestnet Portfolio Solutions bought 209 West Pharmaceutical shares in Q2 2026, an estimated $63.9K.
  • West Pharmaceutical made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #866 holding.
  • Envestnet Portfolio Solutions first reported a position in West Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's West Pharmaceutical position peaked at $4.95M in Q1 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.